| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Prairie Operating Co. | Director | Common Stock | 1.14M | $5.72M | $5.00 | May 3, 2023 | Direct |
| GT Biopharma, Inc. | Executive Chairman/Interim CEO, Director | Common Stock | 856K | $246K | $0.29 | Aug 11, 2023 | Direct |
| Prairie Operating Co. | Director | Stock Option (Right to Buy | 67.5K | Aug 3, 2020 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GTBP | GT Biopharma, Inc. | Aug 11, 2023 | 1 | $57.4K | 4 | Aug 15, 2023 | Executive Chairman/Interim CEO, Director |
| CRKR | Prairie Operating Co. | May 3, 2023 | 5 | $138K | 4 | May 5, 2023 | Director |
| GTBP | GT Biopharma, Inc. | Apr 11, 2023 | 1 | $25K | 4 | Apr 11, 2023 | Executive Chairman/Interim CEO, Director |
| GTBP | GT Biopharma, Inc. | Jan 27, 2023 | 1 | $0 | 4 | Feb 1, 2023 | Exec Chairman and Interim CEO, Director |
| GTBP | GT Biopharma, Inc. | Jul 15, 2022 | 2 | $0 | 4 | Jul 19, 2022 | Exec. Chair. and Interim CEO, Director |
| GTBP | GT Biopharma, Inc. | Feb 16, 2021 | 6 | $170K | 4 | Nov 12, 2021 | Director |
| GTBP | GT Biopharma, Inc. | Jan 13, 2021 | 0 | $0 | 3 | Nov 12, 2021 | Director |